These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32472129)

  • 41. Targeting the EGFR pathway: An alternative strategy for the treatment of tuberous sclerosis complex?
    Schachenhofer J; Gruber VE; Fehrer SV; Haider C; Glatter S; Liszewska E; Höftberger R; Aronica E; Rössler K; Jaworski J; Scholl T; Feucht M
    Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12974. PubMed ID: 38562027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression and vitamin D-mediated regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy skin and in diabetic foot ulcers.
    López-López N; González-Curiel I; Treviño-Santa Cruz MB; Rivas-Santiago B; Trujillo-Paez V; Enciso-Moreno JA; Serrano CJ
    Arch Dermatol Res; 2014 Nov; 306(9):809-21. PubMed ID: 25168880
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
    Jóźwiak S; Nabbout R; Curatolo P;
    Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemical and microscopic studies on giant cells in tuberous sclerosis.
    Jozwiak J; Jozwiak S; Skopinski P
    Histol Histopathol; 2005 Oct; 20(4):1321-6. PubMed ID: 16136513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bleeding solitary SEGA in non-tuberous sclerosis complex adolescent: a case illustration and review of literature.
    Yindeedej V; Rojnueangnit K; Chotsakulthong P; Thamwongskul C
    Childs Nerv Syst; 2024 Jul; 40(7):2199-2207. PubMed ID: 38578478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma.
    Mizuguchi M; Kato M; Yamanouchi H; Ikeda K; Takashima S
    Ann Neurol; 1996 Dec; 40(6):941-4. PubMed ID: 9007104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Response to everolimus in patients with giant cell astrocytoma associated to tuberous sclerosis complex].
    Mateos-González ME; López-Laso E; Vicente-Rueda J; Camino-León R; Fernández-Ramos JA; Baena-Gómez MA; Peña-Rosa MJ
    Rev Neurol; 2014 Dec; 59(11):497-502. PubMed ID: 25418144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Developmental origin of subependymal giant cell astrocytoma in tuberous sclerosis complex.
    Ess KC; Kamp CA; Tu BP; Gutmann DH
    Neurology; 2005 Apr; 64(8):1446-9. PubMed ID: 15851742
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Congenital subpendymal giant cell astrocytoma in children with tuberous sclerosis complex: growth patterns and neurological outcome.
    Chan DL; Kennedy SE; Sarkozy VE; Chung CWT; Flanagan D; Mowat D; Farrar MA; Lawson JA
    Pediatr Res; 2021 May; 89(6):1447-1451. PubMed ID: 32516799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
    Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
    J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
    Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
    Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study.
    Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Berkowitz N; Anak O; Niolat J; Jozwiak S
    Lancet Oncol; 2014 Dec; 15(13):1513-1520. PubMed ID: 25456370
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex-Current Views on Their Pathogenesis and Management.
    Gao C; Zabielska B; Jiao F; Mei D; Wang X; Kotulska K; Jozwiak S
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
    Goffin F; Munaut C; Frankenne F; Perrier D'Hauterive S; Béliard A; Fridman V; Nervo P; Colige A; Foidart JM
    Biol Reprod; 2003 Sep; 69(3):976-84. PubMed ID: 12773401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
    Oh DJ; Martin JL; Williams AJ; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3887-95. PubMed ID: 16936101
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron and microscopic study.
    Hirose T; Scheithauer BW; Lopes MB; Gerber HA; Altermatt HJ; Hukee MJ; VandenBerg SR; Charlesworth JC
    Acta Neuropathol; 1995; 90(4):387-99. PubMed ID: 8546029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MMPs and TIMPs expression in facial tissue of children with cleft lip and palate.
    Smane-Filipova L; Pilmane M; Akota I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):538-542. PubMed ID: 27876897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
    Oh DJ; Martin JL; Williams AJ; Peck RE; Pokorny C; Russell P; Birk DE; Rhee DJ
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):953-63. PubMed ID: 16505029
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura.
    Shin JI; Song KS; Kim H; Cho NH; Kim J; Kim HS; Lee JS
    Br J Dermatol; 2011 Jun; 164(6):1348-55. PubMed ID: 21410660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered expression balance of matrix metalloproteinases and their inhibitors in human carotid plaque disruption: results of quantitative tissue analysis using real-time RT-PCR method.
    Higashikata T; Yamagishi M; Higashi T; Nagata I; Iihara K; Miyamoto S; Ishibashi-Ueda H; Nagaya N; Iwase T; Tomoike H; Sakamoto A
    Atherosclerosis; 2006 Mar; 185(1):165-72. PubMed ID: 16039658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.